Arcosa's Q1 Adjusted EPS Soars to $0.81, Crushing Estimates by Over 100%
ACA sits 62% above its 52-week low of $77.895.
Summary
Arcosa reported a significant beat for its first-quarter adjusted EPS, reaching $0.81 compared to the IBES estimate of $0.37. The company also exceeded analyst expectations across other key metrics, including revenue of $663.3 million (vs. $623.4 million estimate), adjusted net income of $39.6 million (vs. $20.7 million estimate), and adjusted EBITDA of $121.3 million (vs. $101.8 million estimate). This strong performance across all major financial indicators suggests robust operational execution and healthy demand, building on the record financial results reported for 2025. A beat of this magnitude is highly material and will likely be viewed as a strong positive catalyst by traders, potentially driving further upward momentum for the stock, which is already trading near its 52-week high. Investors will now focus on any forward-looking commentary or updated guidance from management.
At the time of this announcement, ACA was trading at $126.47 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6.2B. The 52-week trading range was $77.90 to $131.00. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.